Company News in the Life Science Industry

»

Reset 

New clinical trial for ALK’s house dust mite tablet paves the way for early registration in China

Read more ››
By: GlobenewsWire - 13 Jan 2020

Amarin Launches True To Your Heart, a Campaign to Educate People on Persistent Cardiovascular Risk

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Amarin Corporation plc

Allogene Therapeutics and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate ALLO-715 in Combination with Nirogacestat in Multiple Myeloma

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Allogene Therapeutics, Inc.

Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizer’s Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Axsome Therapeutics, Inc.

Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Acasti Pharma, Inc.

Nanoform Appoints Head of US Sales

HELSINKI, Jan. 13, 2020 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, has appointed Sally Langa as Head of US Sales. The new role will enable Nanoform to continue its rapid growth with a strengthened presence in the US market.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Nanoform

Discover the Latest Information and Seize Market Opportunities in the Annual Event of the CRO & CMO Industry at ICSE China 2020

SHANGHAI, Jan. 13, 2020 /PRNewswire/ -- The ICSE China 2020 will take place in Hall E2, E3/E7 of Shanghai New International Expo Centre from June 22-24, 2020. It will gather Chinese and overseas pharmaceutical experts, showcase advanced products and technologies in the CRO & CMO area and... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Last Patient Included in Sedana Medical's Pivotal IsoConDa Study

STOCKHOLM, Jan. 13, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the last patient has now been included in the pivotal IsoConDa study. Thus, all 300 patients have been included and the study is expected to show top-line results during Q2 2020.

... Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Sedana Medical AB (publ)

Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe

Improved scan rates, higher resolution, and heightened sensitivity attract more verticals towards mass spectroscopy, finds Frost & Sullivan

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020

Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)

CAMBRIDGE, England, Jan. 13, 2020 /PRNewswire/ -- Exonate, an early stage biotechnology company, announced today that it has entered into a strategic collaboration agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Through the collaboration,... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Ambrx and Sino Biopharma Announce Collaboration to Develop Two Next-Generation Biologics

SAN DIEGO and BEIJING, Jan. 13, 2020 /PRNewswire/ -- Ambrx Inc., a clinical-stage biopharmaceutical company focused on the development of next generation biologics using an expanded genetic code and Sino Biopharmaceutical Limited (1177.HK), a leading Chinese pharmaceutical company with a large... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

LONDON, Jan. 13, 2020 /PRNewswire/ -- COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant depression with a psilocybin formulation, by the US Patent and Trademark Office. The patent covers... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

BERKELEY, Calif., Jan. 13, 2020 /PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, announced today that it has raised $25 million in a Series A investment from Vida Ventures and Westlake Village BioPartners,... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Gilead Sciences, Inc

AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

VANCOUVER, Wash., Jan. 13, 2020 /PRNewswire/ -- AbSci, the Protein Printing(TM) company with a best-in-class E. coli cell line for rapid and low-cost biomanufacturing of complex biotherapeutics, today announced the completion of a $10.4M Series D financing led by KBI Biopharma and JSR... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  AbSci

Allscripts Partners With Myndyou to Triage High-risk Patients

NEW YORK, Jan. 13, 2020 /PRNewswire/ -- MyndYou Inc. announced today that they have partnered with Allscripts to make the MyndYou triaging and care management solution available to Allscripts clients, reducing the risk of hospitalization for patients worldwide. This partnership will enable the... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Global Acute Kidney Injury Treatment Market 2019-2027 - Industry Analysis, Size, Share, Growth, Trends, and Forecast

DUBLIN, Jan. 13, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Denis R. Hebert joins autonomous_ID Chairman's Advisory Board

OTTAWA, Jan. 13, 2020 /PRNewswire/ - Autonomous_ID Corporation said today that Denis R. Hebert has joined the Chairman's Advisory Board as a principal advisor on biometric identity and access-control systems. Hebert's appointment comes as the company pivots from research to real-world deployments... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Verona Pharma plc

Acacia Pharma Group plc announces planned CFO succession

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Acacia Pharma

Addex Provides Trading Update and Completes 2019 with Cash Position of CHF31.5 million

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Addex Therapeutics S.A.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Explore our database of over 50,000 companies